The HVAD Left Ventricular Assist Device
Jeffrey J. Teuteberg(Stanford University), Keith D. Aaronson(University of Michigan), Mark S. Slaughter(University of Louisville), Emma J. Birks(Lung Institute), Ulrich P. Jorde(Montefiore Health System), Julia Shin(Montefiore Medical Center), Scott Silvestry(University of Arizona), Randall C. Starling(Cleveland Clinic), J. Eduardo Rame(Thomas Jefferson University Hospital), Kevin B. Najarian(Heartware International (United States)), Francis D. Pagani(Michigan Medicine), Michael Acker, T.P. Schleeter(St. Vincent's Birmingham), Robert L. Kormos(Abbott Northwestern Hospital), Thomas Wozniak(Indiana University Bloomington), Adnan Malik(Loyola University Medical Center), Yoshifumi Naka(Cornell University), Daniel J. Goldstein(Montefiore Medical Center), Christopher T. Salerno(University of Chicago Medical Center), David R. Hathaway(University of Chicago), Joseph G. Rogers(Baylor College of Medicine), Robert Gordon(The University of Texas Health Science Center at Houston), Edwin C. McGee(University of Chicago), Gregory A. Ewald(Washington University in St. Louis)
Cited by 194
Related Papers
The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease
|Circulation|2007|1k
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
|Nature|2016|925
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Pulmonary-Vein Isolation for Atrial Fibrillation in Patients with Heart Failure
|New England Journal of Medicine|2008|763
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757